The task order is to support cgmp manufacturing of the PGT121.414.LS monoclonal antibody (PGT121.414.LS MAB) drug substance from an established manufacturing process, complete the fill finish of the…
Active Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,241,407
Award facts
- Contract value 100% obligated
- $17,241,407.00 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | -$1,505,247 | |
| Change Order | $188,370 | |
| Exercise an Option | $3,161,561 | |
| Original award | $15,396,723 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 10, 2017, with a ceiling value of $17.2 million, for cGMP manufacturing of the PGT121.414.LS monoclonal antibody drug substance and completion of fill-finish operations into drug product, in support of NIAID preclinical development.
Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of December 30, 2028. In fiscal year 2024, the order invoiced $5.4 million across 2.6 FTEs and 5,435 contractor hours, reflecting a derived government-paid blended hourly rate of $986.88 per hour. Subcontractor engagement accounted for 86 percent of reported contractor hours in FY2024, with two subcontractors reported.
Description
The task order is to support cgmp manufacturing of the PGT121.414.LS monoclonal antibody (PGT121.414.LS MAB) drug substance from an established manufacturing process, complete the fill finish of the drug substance (DS) into drug product (DP), quality
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 10, 2017.
How much is contract 75N93023F00001 worth?
The government has obligated $17,241,407 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award